- Home
- ASPN vs IMCR Comparison
ASPN vs IMCR Comparison
Compare ASPN & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- IMCR
- Stock Information
- Founded
- ASPN 2001
- IMCR 2008
- Country
- ASPN United States
- IMCR United Kingdom
- Employees
- ASPN N/A
- IMCR N/A
- Industry
- ASPN RETAIL: Building Materials
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASPN Consumer Discretionary
- IMCR Health Care
- Exchange
- ASPN Nasdaq
- IMCR Nasdaq
- Market Cap
- ASPN 486.5M
- IMCR 1.6B
- IPO Year
- ASPN 2014
- IMCR 2021
- Fundamental
- Price
- ASPN $6.65
- IMCR $35.40
- Analyst Decision
- ASPN Strong Buy
- IMCR Buy
- Analyst Count
- ASPN 10
- IMCR 10
- Target Price
- ASPN $21.78
- IMCR $58.13
- AVG Volume (30 Days)
- ASPN 1.5M
- IMCR 389.0K
- Earning Date
- ASPN 08-06-2025
- IMCR 08-07-2025
- Dividend Yield
- ASPN N/A
- IMCR N/A
- EPS Growth
- ASPN N/A
- IMCR N/A
- EPS
- ASPN N/A
- IMCR N/A
- Revenue
- ASPN $436,921,000.00
- IMCR $333,581,000.00
- Revenue This Year
- ASPN N/A
- IMCR $26.82
- Revenue Next Year
- ASPN $24.31
- IMCR $8.15
- P/E Ratio
- ASPN N/A
- IMCR N/A
- Revenue Growth
- ASPN 51.90
- IMCR 25.75
- 52 Week Low
- ASPN $4.16
- IMCR $23.15
- 52 Week High
- ASPN $33.15
- IMCR $41.54
- Technical
- Relative Strength Index (RSI)
- ASPN 59.86
- IMCR 58.66
- Support Level
- ASPN $6.17
- IMCR $32.20
- Resistance Level
- ASPN $7.18
- IMCR $35.75
- Average True Range (ATR)
- ASPN 0.38
- IMCR 1.24
- MACD
- ASPN 0.10
- IMCR 0.29
- Stochastic Oscillator
- ASPN 78.96
- IMCR 81.51
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.